designed to be incorporated into a primary research consent document. The use of the sample
language by itself does not address federal, state, local, tribal, or international requirements that may
apply to the primary research. Furthermore, this resource is designed for research consent documents;
it does not address the storage and sharing of data and biospecimens initially collected for clinical
purposes. Use of the information provided in this resource, including sample language, is completely
voluntary.
II. Instructions for Use:
This document presents points to consider, instructions for use, and optional sample language that is
designed for informed consent documents for research studies that include plans to store and share
collected data and biospecimens for future use. The use of the suggested language does not obviate the
need for IRB review and approval of any non-exempt secondary research. The sample consent language
provided in the resource does not supplant the primary study’s informed consent document, but rather
is intended to be incorporated into the primary study’s consent document. This resource is not a
comprehensive informed consent document, nor is it presented in any specific order. Not all of the
components will need to be included in every informed consent document. The sample language will
need to be tailored to institutional and study specific requirements. The sample language does not
address all possible scenarios for which informed consent may be needed for data and biospecimen
storage and sharing. It is the responsibility of researchers and institutional review boards (IRBs) to
determine the appropriate use of the sample language including which components, if any, are relevant
to a primary consent and the most appropriate section to incorporate the sample language. Researchers
should carefully select language appropriate for the study, and IRBs should ensure that the study’s
primary consent meets all applicable regulatory and policy requirements, including federal, state, local,
Tribal, and international requirements.
Use of this sample language is completely voluntary. This language is being provided as a resource for
the research community, and there are no requirements or expectations that any portion of the
language be used in an informed consent document for NIH-supported or -conducted studies.
The scope of this resource encompasses consent for storage and sharing of individually identifiable and
deidentified data and biospecimens. “Data and biospecimens” includes information collected from, or
about a research participant during the course of a primary study (e.g., surveys, medical images,
electronic health records, wearable device information) as well as human material (e.g., blood, tissue,
urine, extracted DNA).
This resource addresses only consent for the storage and sharing of data and biospecimens collected
during a primary research protocol, for the purposes of future secondary research. The approval for use
of these data and biospecimens in new research studies that are outside the scope of the primary
protocol and consent (i.e., secondary research) will need to be met through other means. This may
include IRB approval of the secondary research project, and if necessary, re-consent, or a waiver of
consent, even if participants have indicated their agreement to storage and sharing for future use (45
CFR 46.111, 46.116). Note that under the Common Rule, the primary consent should address
requirements for notifying research participants that identifiers may be removed and that the data and
samples may be used for future research without additional consent (45 CFR 46.116(b)(9)(i)).
2